Philogen

Philogen is a clinical-stage biotechnology company focused on the development of antibody-based treatments. Philogen currently has two candidate products in Phase 3 clinical trials for oncology indications. One is a drug called Daromun, used to treat stage 3 melanoma after complete surgical resection, and the other is Fibromun, used to treat metastatic soft tissue sarcoma.